FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102016076> ?p ?o ?g. }

• W2102016076 endingPage "770" @default.
• W2102016076 startingPage "762" @default.
• W2102016076 abstract "Triple reuptake inhibitors (TRIs) that block the dopamine transporter (DAT), norepinephrine transporter, and serotonin transporter are being developed as a new class of antidepressant that may have better efficacy and fewer side effects compared with traditional antidepressants. We describe a novel TRI, 2-[4-(4-chlorophenyl)-1-methylpiperidin-3-ylmethylsulfanyl]-1-(3-methylpiperidin-1-yl)-ethanone (JZAD-IV-22), that inhibits all three monoamine transporters with approximately equal potency in vitro. (+/-)-1-(3,4-dichlorophenyl)-3-azabicyclo-[3.1.0]hexane hydrochloride (DOV 216,303), a TRI shown to be an effective antidepressant in a clinical trial, shows reuptake inhibition similar to that of JZAD-IV-22 in vitro. Furthermore, both JZAD-IV-22 and DOV 216,303 increase levels of dopamine, norepinephrine, and serotonin in the mouse prefrontal cortex when administered by peripheral injection. JZAD-IV-22 and DOV 216,303 exhibited antidepressant-like efficacy in the mouse forced-swim and tail-suspension tests at doses that increased neurotransmitter levels. Because development of DAT inhibitors could be hindered by abuse liability, both JZAD-IV-22 and DOV 216,303 were compared in two assays that are markers of abuse potential. Both JZAD-IV-22 and DOV 216,303 partially substituted for cocaine in a drug discrimination assay in rats, and high doses of DOV 216,303 produced locomotor sensitization in mice. JZAD-IV-22 showed no evidence of sensitization at any dose tested. These results demonstrate that JZAD-IV-22 is a TRI with antidepressant-like activity similar to that of DOV 216,303. The striking feature that distinguishes the two TRIs is that locomotor sensitization, a common underlying feature of drugs of abuse, is seen with DOV 216,303 but is completely lacking in JZAD-IV-22. These findings may have implications for the potential for abuse liability in humans." @default.
• W2102016076 created "2016-06-24" @default.
• W2102016076 creator A5004200655 @default.
• W2102016076 creator A5009706192 @default.
• W2102016076 creator A5014019906 @default.
• W2102016076 creator A5014199484 @default.
• W2102016076 creator A5019442722 @default.
• W2102016076 creator A5020116287 @default.
• W2102016076 creator A5023901418 @default.
• W2102016076 creator A5026395120 @default.
• W2102016076 creator A5026623910 @default.
• W2102016076 creator A5031405260 @default.
• W2102016076 creator A5066067760 @default.
• W2102016076 date "2010-09-23" @default.
• W2102016076 modified "2023-09-25" @default.
• W2102016076 title "The Novel Triple Reuptake Inhibitor JZAD-IV-22 Exhibits an Antidepressant Pharmacological Profile without Locomotor Stimulant or Sensitization Properties" @default.
• W2102016076 cites W1977430165 @default.
• W2102016076 cites W1985352992 @default.
• W2102016076 cites W1986641829 @default.
• W2102016076 cites W1987152895 @default.
• W2102016076 cites W1993584299 @default.
• W2102016076 cites W1994956076 @default.
• W2102016076 cites W1997428008 @default.
• W2102016076 cites W2004030834 @default.
• W2102016076 cites W2007604257 @default.
• W2102016076 cites W2007689138 @default.
• W2102016076 cites W2010883604 @default.
• W2102016076 cites W2013139515 @default.
• W2102016076 cites W2015370635 @default.
• W2102016076 cites W2017505816 @default.
• W2102016076 cites W2019647316 @default.
• W2102016076 cites W2022406556 @default.
• W2102016076 cites W2023504580 @default.
• W2102016076 cites W2033437417 @default.
• W2102016076 cites W2041780263 @default.
• W2102016076 cites W2045122130 @default.
• W2102016076 cites W2048060693 @default.
• W2102016076 cites W2065929137 @default.
• W2102016076 cites W2065953886 @default.
• W2102016076 cites W2067998521 @default.
• W2102016076 cites W2071328685 @default.
• W2102016076 cites W2073374285 @default.
• W2102016076 cites W2106862702 @default.
• W2102016076 cites W2110307387 @default.
• W2102016076 cites W2122592499 @default.
• W2102016076 cites W2131202975 @default.
• W2102016076 cites W2149765291 @default.
• W2102016076 cites W2155709733 @default.
• W2102016076 cites W2156809536 @default.
• W2102016076 cites W2160402497 @default.
• W2102016076 cites W4231169313 @default.
• W2102016076 doi "https://doi.org/10.1124/jpet.110.174011" @default.
• W2102016076 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2993553" @default.
• W2102016076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20864506" @default.
• W2102016076 hasPublicationYear "2010" @default.
• W2102016076 type Work @default.
• W2102016076 sameAs 2102016076 @default.
• W2102016076 citedByCount "25" @default.
• W2102016076 countsByYear W21020160762012 @default.
• W2102016076 countsByYear W21020160762013 @default.
• W2102016076 countsByYear W21020160762014 @default.
• W2102016076 countsByYear W21020160762015 @default.
• W2102016076 countsByYear W21020160762017 @default.
• W2102016076 countsByYear W21020160762019 @default.
• W2102016076 countsByYear W21020160762021 @default.
• W2102016076 crossrefType "journal-article" @default.
• W2102016076 hasAuthorship W2102016076A5004200655 @default.
• W2102016076 hasAuthorship W2102016076A5009706192 @default.
• W2102016076 hasAuthorship W2102016076A5014019906 @default.
• W2102016076 hasAuthorship W2102016076A5014199484 @default.
• W2102016076 hasAuthorship W2102016076A5019442722 @default.
• W2102016076 hasAuthorship W2102016076A5020116287 @default.
• W2102016076 hasAuthorship W2102016076A5023901418 @default.
• W2102016076 hasAuthorship W2102016076A5026395120 @default.
• W2102016076 hasAuthorship W2102016076A5026623910 @default.
• W2102016076 hasAuthorship W2102016076A5031405260 @default.
• W2102016076 hasAuthorship W2102016076A5066067760 @default.
• W2102016076 hasBestOaLocation W21020160762 @default.
• W2102016076 hasConcept C126322002 @default.
• W2102016076 hasConcept C137183658 @default.
• W2102016076 hasConcept C170493617 @default.
• W2102016076 hasConcept C176233148 @default.
• W2102016076 hasConcept C185592680 @default.
• W2102016076 hasConcept C187714386 @default.
• W2102016076 hasConcept C203014093 @default.
• W2102016076 hasConcept C2775864247 @default.
• W2102016076 hasConcept C2776217527 @default.
• W2102016076 hasConcept C2776755682 @default.
• W2102016076 hasConcept C2778514916 @default.
• W2102016076 hasConcept C2779177272 @default.
• W2102016076 hasConcept C2781063702 @default.
• W2102016076 hasConcept C2781161787 @default.
• W2102016076 hasConcept C31487548 @default.
• W2102016076 hasConcept C513476851 @default.
• W2102016076 hasConcept C71924100 @default.
• W2102016076 hasConcept C98274493 @default.
• W2102016076 hasConcept C99631742 @default.
• W2102016076 hasConceptScore W2102016076C126322002 @default.

• next